Comparison

Losartan potassium impurity E European Partner

Item no. TMO-T20126-1g
Manufacturer TargetMol
CASRN 120568-11-8
Amount 1 g
Quantity options 100 mg 1 g 200 mg 25 mg 500 mg 50 mg
Category
Type Molecules
Specific against other
Citations Wei YL, Du HJ, Lin YP, Wu ML, Xu RA. Effects of salidroside on rat CYP enzymes by a cocktail of probe drugs. Iran J Basic Med Sci. 2018 Apr;21(4):422-426. doi: 10.22038/IJBMS.2018.26106.6414. PubMed PMID: 29796228; PubMed Central PMCID: PMC5960761.
Smiles CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias L-158507,L 158507,L158507
Shipping Condition Cool pack
Available
Manufacturer - Targets
Others
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
236.27
Description
Losartan potassium impurity E is a compound of Valsartan impurity.
Pathways
Others

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 g
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?